Johnson & Johnson (JNJ.N) News| Reuters.com
Edition:
United States

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

117.70USD
12:43pm EDT
Change (% chg)

$1.15 (+0.99%)
Prev Close
$116.55
Open
$117.00
Day's High
$117.85
Day's Low
$116.55
Volume
1,183,431
Avg. Vol
2,504,205
52-wk High
$117.85
52-wk Low
$81.79

Select another date:

Fri, Jun 24 2016

J&J asks 5th Circuit to delay next Pinnacle hip bellwether trial

Johnson & Johnson and its DePuy Orthopaedics unit have asked a federal appeals court to halt an upcoming bellwether trial over their Pinnacle metal-on-metal hip implants until their challenges to a previous $502 million verdict are resolved.

J&J files new lawsuit to block biosimilar version of Remicade

Johnson & Johnson has filed a second patent lawsuit against South Korean drug maker Celltrion Inc and Pfizer Inc's Hospira unit to stop them from launching a cheaper version of J&J's arthritis and inflammatory bowel drug Remicade in the U.S.

BRIEF-Amyris announces collaboration with Johnson & Johnson Innovation

* Amyris announces collaboration with Johnson & Johnson innovation for biosynthetic drug discovery

J&J myeloma drug, in combo regimen, delays worsening of the disease

Johnson & Johnson's therapy for advanced multiple myeloma sharply reduced the risk of disease progression when taken with two standard treatments for the blood cancer, according to research the company hopes will pave the way for wider use of the treatment.

J&J myeloma drug, in combo regimen, delays worsening of the disease

June 5 Johnson & Johnson's therapy for advanced multiple myeloma sharply reduced the risk of disease progression when taken with two standard treatments for the blood cancer, according to research the company hopes will pave the way for wider use of the treatment.

J&J to buy hair care products maker Vogue for $3.3 billion

Johnson & Johnson said on Thursday it would acquire Vogue International for $3.3 billion, adding brands such as OGX shampoos and FX hair styling products to its consumer portfolio that includes Neutrogena and Clean & Clear.

UPDATE 2-J&J to buy hair care products maker Vogue for $3.3 bln

June 2 Johnson & Johnson said on Thursday it would acquire Vogue International for $3.3 billion, adding brands such as OGX shampoos and FX hair styling products to its consumer portfolio that includes Neutrogena and Clean & Clear.

J&J to buy hair care products maker Vogue for $3.3 bln

June 2 Johnson & Johnson said on Thursday it would acquire Vogue International, a privately held hair care and personal care products maker, for about $3.3 billion in cash.

BRIEF-Johnson & Johnson to acquire Vogue International for about $3.3 bln

* Johnson & Johnson announces agreement to acquire Vogue International

BRIEF-European Commission approves Johnson & Johnson's TREVICTA

* Janssen-Cilag International NV says European Commission (EC) has approved use of TREVICTA for maintenance treatment of schizophrenia in adult patients Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Select another date: